Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

A Different Approach to Preventing Thrombosis

Conditions:   Venous Thromboembolism;   Pulmonary Embolism
Interventions:   Drug: VTE prophylaxis with Enoxaparin 30mg BID;   Drug: VTE prophylaxis with Aspirin 81mg BID
Sponsor:   University of Maryland
Recruiting - verified May 2016

Inferior Vena Cava Retrievable Filters: Spanish Register

Condition:   Vena Cava Filters
Intervention:   Other: Inferior vena cava filter placement and retrieval
Sponsors:   Group of Research in Minimally Invasive Techniques;   SERVEI (Sociedad Española de Radiología Vascular e Intervencionista)
Not yet recruiting - verified May 2016

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

Conditions:   Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot;   VTE
Interventions:   Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
Sponsors:   Alliance Foundation Trials, LLC.;   Patient-Centered Outcomes Research Institute
Not yet recruiting - verified May 2016

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Condition:   Venous Thrombosis and Pulmonary Embolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Not yet recruiting - verified May 2016

Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial

Conditions:   Thrombophilia Associated With Pregnancy;   Perioperative/Postoperative Complications;   Venous Thrombosis;   Pulmonary Embolism;   Other Specified Risk Factors in Pregnancy;   Deep Vein Thrombosis
Interventions:   Drug: Enoxaparin;   Other: No intervention
Sponsor:   University of Sao Paulo General Hospital
Recruiting - verified May 2016

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)

Condition:   Venous Thromboembolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Recruiting - verified May 2016

A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban;   Drug: Standard-of-care
Sponsors:   Janssen Scientific Affairs, LLC;   Bayer
Recruiting - verified May 2016

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Condition:   Cancer
Interventions:   Drug: Rivaroxaban;   Drug: Placebo
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified May 2016

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified May 2016

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:  
Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR)
Recruiting - verified May 2016

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

Conditions:   Venous Thromboembolism;   Pulmonary Embolism;   Thromboprophylaxis
Intervention:   Drug: Enoxaparin
Sponsor:   Tampere University Hospital
Recruiting - verified May 2016

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

Condition:   Pulmonary Embolism
Intervention:   Device: IVC Filter
Sponsors:   New England Research Institutes;   IVC Filter Study Group Foundation (IDE Sponsor);   ALN Implants Chirurgicaux;   B. Braun Interventional Systems, Inc;   Bard Peripheral Vascular, Inc.;   Cook;   Cordis Corporation;   Volcano Corporation;   Rex Medical
Recruiting - verified October 2015

Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)

Conditions:   Wounds and Injuries;   Acute Coagulopathy
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsors:   National Trauma Research Institute;   National Health and Medical Research Council, Australia
Recruiting - verified May 2016

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

Conditions:   Permanent Atrial Fibrillation;   Venous Thrombosis;   Pulmonary Embolism;   Anticoagulation Treatment at Least > or = to 12-month
Interventions:   Drug: Rivaroxaban;   Drug: Fluindione;   Drug: Warfarin
Sponsor:   University Hospital, Angers
Recruiting - verified May 2016

Cook IVC Filter Study

Condition:   Pulmonary Embolism
Intervention:   Device: Günther Tulip® Vena Cava Filter and Cook Celect® Vena Cava Filters
Sponsor:   Cook
Recruiting - verified May 2016

Prehospital Tranexamic Acid Use for Traumatic Brain Injury

Condition:   Traumatic Brain Injury
Interventions:   Drug: 1 gram Tranexamic Acid (TXA);   Drug: 2 grams TXA;   Drug: 0.9% Sodium Chloride injectable
Sponsors:   University of Washington;   National Heart, Lung, and Blood Institute (NHLBI);   U.S. Army Medical Research and Materiel Command;   Canadian Institutes of Health Research (CIHR);   Heart and Stroke Foundation of Canada;   American Heart Association;   Defence Research and Development Canada
Recruiting - verified May 2016

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Recruiting - verified May 2016

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Condition:   Unsuspected Pulmonary Embolism
Intervention:   Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
Sponsor:   G. d'Annunzio University
Recruiting - verified May 2016

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia

Conditions:   Medical Patient;   Thrombocytopenia
Intervention:   Drug: Fondaparinux
Sponsor:   G. d'Annunzio University
Active, not recruiting - verified May 2016

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2016

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2016

Obstructive Sleep Apnea and Venous Thromboembolism

Conditions:   Obstructive Sleep Apnea;   Venous Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism
Intervention:  
Sponsor:   University of Missouri-Columbia
Withdrawn - verified May 2016

Point of Care Ultrasound (US) Versus Detailed Radiology US for Deep Vein Thrombosis (DVT)

Condition:   DEEP VEIN THROMBOSIS
Intervention:  
Sponsor:   University of Missouri-Columbia
Withdrawn - verified May 2016

Clinical and Economic Implications of Genetic Testing for Warfarin Management

Condition:   Blood Coagulation Disorders
Intervention:   Drug: Warfarin
Sponsors:   University of Chicago;   Agency for Healthcare Research and Quality (AHRQ)
Active, not recruiting - verified May 2016

Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services

Condition:   Thrombosis
Intervention:   Behavioral: Observation
Sponsor:   University of Chicago
Active, not recruiting - verified May 2016

Epidemiology of Venous Thrombosis and Pulmonary Embolism

Conditions:   Cardiovascular Diseases;   Pulmonary Embolism;   Venous Thrombosis
Intervention:  
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified May 2016

Incidence and Outcomes of Venous Thromboembolism

Conditions:   Cardiovascular Diseases;   Lung Diseases;   Pulmonary Embolism;   Venous Thromboembolism
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified September 2002